The Clinical and Translational Science Institute (CTSI) has received a $5.3 million grant from the National Institutes of Health to continue the K12 Scholars Career Development Program.

The K12 program is co-led by SPH Professor Tetyana Shippee, who benefited as a participant in the program as an early career scientist. The program provides comprehensive career development support for early-career faculty, and is one part of CTSI’s overarching efforts to train a strong, diverse, clinical and translational science workforce.

This award is linked to the $53.9 million in CTSA funding that CTSI received in September, along with the funding it anticipates receiving for its T32 predoctoral and postdoctoral training programs in the coming months.

The award builds on the highly successful and popular KL2 program, which Shippee was a part of and now co-leads. The programs’s goal is to help assistant professors conducting clinical or translational research become successful, independent, effective team scientists and leaders. The program provides these scholars with rigorous training, promotes their personal and career development, and surrounds each scholar with a multidisciplinary team of mentors.

Because this program now receives funding through NIH’s K12 funding mechanism (not the KL2 mechanism as with the previous CTSA grant), CTSI has made a slight change to the name of the program. CTSI’s KL2 Scholars Career Development Program is now the K12 Scholars Career Development Program. The program’s purpose and dedicated support for scholars remains the same.

The award started February 1, 2024 and runs through January 31, 2029.

A version of this article originally appeared on CTSI’s website.